Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 8/20 | 0.59 |
| ▸ | HTT | P42858 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.57 |
| ▸ | RAD52 | P43351 | 2/20 | 0.57 |
| ▸ | RECQL | P46063 | 2/20 | 0.50 |
| ▸ | BBOX1 | O75936 | 2/20 | 0.50 |
| ▸ | GLA | P06280 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.40 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.40 |
| ▸ | LSS | P48449 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6243130 | 1.00 | DNM1 (0.59) | DNM1HTTKMT2AHSP90AA1RAD52 | |
| SCHEMBL608118 | 1.00 | DNM1 (0.59) | DNM1HTTKMT2AHSP90AA1RAD52 | |
| SCHEMBL6900640 | 1.00 | DNM1 (0.59) | DNM1HTTKMT2AHSP90AA1RAD52 | |
| SCHEMBL1123347 | 1.00 | DNM1 (0.59) | DNM1HTTKMT2AHSP90AA1RAD52 | |
| SCHEMBL2904189 | 1.00 | DNM1 (0.59) | DNM1HTTKMT2AHSP90AA1RAD52 | |
| SCHEMBL12760650 | 1.00 | DNM1 (0.59) | DNM1HTTKMT2AHSP90AA1RAD52 | |
| Hydrochloric Acid SCHEMBL20496970 | 0.98 | DNM1 (0.57) | DNM1HTTKMT2AHSP90AA1RAD52 | |
| Mecetronium SCHEMBL11855665 | 0.97 | DNM1 (0.55) | DNM1HTTKMT2AHSP90AA1RAD52 | |
| SCHEMBL14742775 | 0.95 | BBOX1 (0.55) | DNM1HTTKMT2AHSP90AA1RAD52 | |
| SCHEMBL14743251 | 0.95 | BBOX1 (0.55) | DNM1HTTKMT2AHSP90AA1RAD52 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 359 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4661968-A1 | DIHYDROTRIAZINE COMPOUND AND COMPOSITION FOR USE IN PODOLOGY, IN THE PROPHYLAXIS AND/OR TREATMENT OF FOOT DISORDERS, THE TREATMENT OF TATTOOS AND/OR TATTOO WOUNDS AND THE TREATMENT OF A PIERCING AND/OR PIERCING WOUNDS | B. Braun Melsungen AG (DE) | 2025-12-17 | — | — | EP | claimed |
| EP-4661674-A1 | ANTIMICROBIAL MEDICAL PRODUCT | B. Braun Melsungen AG (DE) | 2025-12-17 | — | — | EP | claimed |
| US-12274830-B2 | Nitric oxide inhalation therapy for infants with bronchiolitis | BEYOND AIR LTD (IL) | 2025-04-15 | — | — | US | claimed |
| WO-2024165485-A1 | DIHYDROTRIAZINE COMPOUND AND COMPOSITION FOR USE IN PODOLOGY, IN THE PROPHYLAXIS AND/OR TREATMENT OF FOOT DISORDERS, THE TREATMENT OF TATTOOS AND/OR TATTOO WOUNDS AND THE TREATMENT OF A PIERCING AND/OR PIERCING WOUNDS | B. BRAUN MELSUNGEN AG (DE) | 2024-08-15 | — | — | WO | claimed |
| WO-2024165496-A1 | ANTIMICROBIAL MEDICAL PRODUCT | B. BRAUN MELSUNGEN AG (DE) | 2024-08-15 | — | — | WO | claimed |
| US-20240173512-A1 | METHODS FOR POTENTIATING ANTIMICROBIAL AGENTS | STREETERVILLE CAPITAL, LLC | 2024-05-30 | — | — | US | claimed |
| US-11890421-B2 | Methods for potentiating antimicrobial agents | BEYOND AIR LTD (IL) | 2024-02-06 | — | — | US | claimed |
| US-20230413810-A1 | SANITISING FORMULATION | LUMENDO AG (CH) | 2023-12-28 | — | — | US | claimed |
| EP-4195922-A1 | SANITISING FORMULATION | Lumendo AG (CH) | 2023-06-21 | — | — | EP | claimed |
| US-20220408729-A1 | COMPOSITIONS CONTAINING METALLIC COMPOUNDS FOR PROLONGED DISINFECTION OF SURFACES AND THEIR USES | NANOMATERIALES QUIMICOS AVANZADOS, S.A. DE C.V. (MX) | 2022-12-29 | — | — | US | claimed |
| EP-0657896-B1 | Method of making bubble and foreign particle free electrically conductive polyurethanes | XEROX CORP (US) | 2003-03-26 | — | — | EP | claimed |
| EP-1080715-A2 | Combination of active agents and compositions for foot-care containing it | Bode Chemie GmbH & Co. (DE) | 2001-03-07 | — | — | EP | claimed |
| EP-0556546-B1 | Viricidal disinfecting composition | BODE CHEMIE GMBH & CO (DE) | 2000-10-18 | — | — | EP | claimed |
| US-5454980-A | Method of making bubble and foreign particle free electrically conductive polyurethanes | XEROX CORPORATION (US) | 1995-10-03 | — | — | US | claimed |
| EP-0657896-A1 | Method of making bubble and foreign particle free electrically conductive polyurethanes | XEROX CORPORATION (US) | 1995-06-14 | — | — | EP | claimed |
| US-5286566-A | Crosslinked chain extended polyetherurethane copolymer and asymmetric ionic quaternary ammonium salt | XEROX CORPORATION (US) | 1994-02-15 | — | — | US | claimed |
| US-5259989-A | Polyurethane obtained from polytetramethylene ether glycol, at least one diisocyanate, crosslinking agents, chain extenders; asymmetric tetraalkylammonium alkyl sulfate | XEROX CORPORATION (US) | 1993-11-09 | — | — | US | claimed |
| EP-0556546-A2 | Viricidal disinfecting composition | Bode Chemie GmbH & Co. (DE) | 1993-08-25 | — | — | EP | claimed |
| EP-0555634-A2 | Disinfection compositions | Bode Chemie GmbH & Co. (DE) | 1993-08-18 | — | — | EP | claimed |
| EP-0238994-B1 | PROCESS FOR PREPARING HIGH PURITY DERMATAN-SULPHATE, AND PHARMACEUTICAL COMPOSITIONS WICH CONTAIN IT | MEDIOLANUM FARMACEUTICI s.r.l. (IT) | 1991-07-17 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230413810-A1 | SANITISING FORMULATION | LPO, WASHC5, GFER | DNM1 1033/4885HTT 1680/4885KMT2A 3352/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.